<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37048088</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>26</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Intramuscular IL-10 Administration Enhances the Activity of Myogenic Precursor Cells and Improves Motor Function in ALS Mouse Model.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1016</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells12071016</ELocationID><Abstract><AbstractText>Amyotrophic Lateral Sclerosis (ALS) is the most common adult motor neuron disease, with a poor prognosis, a highly unmet therapeutic need, and a burden on health care costs. Hitherto, strategies aimed at protecting motor neurons have missed or modestly delayed ALS due to a failure in countering the irreversible muscular atrophy. We recently provided direct evidence underlying the pivotal role of macrophages in preserving skeletal muscle mass. Based on these results, we explored whether the modulation of macrophage muscle response and the enhancement of satellite cell differentiation could effectively promote the generation of new myofibers and counteract muscle dysfunction in ALS mice. For this purpose, disease progression and the survival of SOD1G93A mice were evaluated following IL-10 injections in the hindlimb skeletal muscles. Thereafter, we used ex vivo methodologies and in vitro approaches on primary cells to assess the effect of the treatment on the main pathological signatures. We found that IL-10 improved the motor performance of ALS mice by enhancing satellite cells and the muscle pro-regenerative activity of macrophages. This resulted in delayed muscle atrophy and motor neuron loss. Our findings provide the basis for a suitable adjunct multisystem therapeutic approach that pinpoints a primary role of muscle pathology in ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fabbrizio</LastName><ForeName>Paola</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-1843-2605</Identifier><AffiliationInfo><Affiliation>Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Margotta</LastName><ForeName>Cassandra</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-4957-5924</Identifier><AffiliationInfo><Affiliation>Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Agostino</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1924-7161</Identifier><AffiliationInfo><Affiliation>Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suanno</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-0408-0584</Identifier><AffiliationInfo><Affiliation>Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quetti</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bendotti</LastName><ForeName>Caterina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-1055-1271</Identifier><AffiliationInfo><Affiliation>Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nardo</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-1803-1484</Identifier><AffiliationInfo><Affiliation>Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>130068-27-8</RegistryNumber><NameOfSubstance UI="D016753">Interleukin-10</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016753" MajorTopicYN="N">Interleukin-10</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009133" MajorTopicYN="N">Muscular Atrophy</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic Lateral Sclerosis</Keyword><Keyword MajorTopicYN="N">macrophages</Keyword><Keyword MajorTopicYN="N">mouse models</Keyword><Keyword MajorTopicYN="N">myogenic precursor cells</Keyword><Keyword MajorTopicYN="N">skeletal muscle</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>1</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37048088</ArticleId><ArticleId IdType="pmc">PMC10093513</ArticleId><ArticleId IdType="doi">10.3390/cells12071016</ArticleId><ArticleId IdType="pii">cells12071016</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mejzini R., Flynn L.L., Pitout I.L., Fletcher S., Wilton S.D., Akkari P.A. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front. Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P., van Damme P. Amyotrophic Lateral Sclerosis: A Clinical Review. Eur. J. Neurol. 2020;27:1918&#x2013;1929. doi: 10.1111/ene.14393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Moloney E.B., de Winter F., Verhaagen J. ALS as a Distal Axonopathy: Molecular Mechanisms Affecting Neuromuscular Junction Stability in the Presymptomatic Stages of the Disease. Front. Neurosci. 2014;8:252. doi: 10.3389/fnins.2014.00252.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2014.00252</ArticleId><ArticleId IdType="pmc">PMC4132373</ArticleId><ArticleId IdType="pubmed">25177267</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha M.C., Pousinha P.A., Correia A.M., Sebasti&#xe3;o A.M., Ribeiro J.A. Early Changes of Neuromuscular Transmission in the SOD1(G93A) Mice Model of ALS Start Long before Motor Symptoms Onset. PLoS ONE. 2013;8:e73846. doi: 10.1371/journal.pone.0073846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0073846</ArticleId><ArticleId IdType="pmc">PMC3764017</ArticleId><ArticleId IdType="pubmed">24040091</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer L.R., Glass J.D. Axonal Degeneration in Motor Neuron Disease. Neurodegener. Dis. 2007;4:431&#x2013;442. doi: 10.1159/000107704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000107704</ArticleId><ArticleId IdType="pubmed">17934327</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., Khan J., Polak M.A., Glass J.D. Amyotrophic Lateral Sclerosis Is a Distal Axonopathy: Evidence in Mice and Man. Exp. Neurol. 2004;185:232&#x2013;240. doi: 10.1016/j.expneurol.2003.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaricamazza S., Salvatori I., Ferri A., Valle C. Skeletal Muscle in ALS: An Unappreciated Therapeutic Opportunity? Cells. 2021;10:525. doi: 10.3390/cells10030525.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10030525</ArticleId><ArticleId IdType="pmc">PMC8000428</ArticleId><ArticleId IdType="pubmed">33801336</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzano R., Toivonen J.M., Moreno-Mart&#xed;nez L., Torre M., Moreno-Garc&#xed;a L., L&#xf3;pez-Royo T., Molina N., Zaragoza P., Calvo A.C., Osta R. What Skeletal Muscle Has to Say in Amyotrophic Lateral Sclerosis: Implications for Therapy. Br. J. Pharmacol. 2021;178:1279&#x2013;1297. doi: 10.1111/bph.15276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15276</ArticleId><ArticleId IdType="pubmed">32986860</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G., Aucello M., Rizzuto E., Beccafico S., Mammucari C., Bonconpagni S., Belia S., Wannenes F., Nicoletti C., del Prete Z., et al. Skeletal Muscle Is a Primary Target of SOD1G93A-Mediated Toxicity. Cell Metab. 2008;8:425&#x2013;436. doi: 10.1016/j.cmet.2008.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2008.09.002</ArticleId><ArticleId IdType="pubmed">19046573</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong M., Martin L.J. Skeletal Muscle-Restricted Expression of Human SOD1 Causes Motor Neuron Degeneration in Transgenic Mice. Hum. Mol. Genet. 2010;19:2284&#x2013;2302. doi: 10.1093/hmg/ddq106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq106</ArticleId><ArticleId IdType="pmc">PMC2865380</ArticleId><ArticleId IdType="pubmed">20223753</ArticleId></ArticleIdList></Reference><Reference><Citation>Rios R., Jablonka-Shariff A., Broberg C., Snyder-Warwick A.K. Macrophage Roles in Peripheral Nervous System Injury and Pathology: Allies in Neuromuscular Junction Recovery. Mol. Cell. Neurosci. 2021;111:103590. doi: 10.1016/j.mcn.2021.103590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2021.103590</ArticleId><ArticleId IdType="pmc">PMC8235592</ArticleId><ArticleId IdType="pubmed">33422671</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo G., Trolese M.C., de Vito G., Cecchi R., Riva N., Dina G., Heath P.R., Quattrini A., Shaw P.J., Piazza V., et al. Immune Response in Peripheral Axons Delays Disease Progression in SOD1G93A Mice. J. Neuroinflammation. 2016;13:261. doi: 10.1186/s12974-016-0732-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0732-2</ArticleId><ArticleId IdType="pmc">PMC5055725</ArticleId><ArticleId IdType="pubmed">27717377</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiraishi W., Yamasaki R., Hashimoto Y., Ko S., Kobayakawa Y., Isobe N., Matsushita T., Kira J.-I. Clearance of Peripheral Nerve Misfolded Mutant Protein by Infiltrated Macrophages Correlates with Motor Neuron Disease Progression. Sci. Rep. 2021;11:16438. doi: 10.1038/s41598-021-96064-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-96064-6</ArticleId><ArticleId IdType="pmc">PMC8360983</ArticleId><ArticleId IdType="pubmed">34385589</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber S., Schreiber F., Garz C., Debska-Vielhaber G., Assmann A., Perosa V., Petri S., Dengler R., Nestor P., Vielhaber S. Toward in Vivo Determination of Peripheral Nervous System Immune Activity in Amyotrophic Lateral Sclerosis. Muscle Nerve. 2019;59:567&#x2013;576. doi: 10.1002/mus.26444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26444</ArticleId><ArticleId IdType="pubmed">30734322</ArticleId></ArticleIdList></Reference><Reference><Citation>Trolese M.C., Scarpa C., Melfi V., Fabbrizio P., Sironi F., Rossi M., Bendotti C., Nardo G. Boosting the Peripheral Immune Response in the Skeletal Muscles Improved Motor Function in ALS Transgenic Mice. Mol. Ther. 2022;30:2760&#x2013;2784. doi: 10.1016/j.ymthe.2022.04.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2022.04.018</ArticleId><ArticleId IdType="pmc">PMC9372324</ArticleId><ArticleId IdType="pubmed">35477657</ArticleId></ArticleIdList></Reference><Reference><Citation>Musar&#xf2; A. The Basis of Muscle Regeneration. Adv. Biol. 2014;2014:612471. doi: 10.1155/2014/612471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/612471</ArticleId></ArticleIdList></Reference><Reference><Citation>Tidball J.G. Regulation of Muscle Growth and Regeneration by the Immune System. Nat. Rev. Immunol. 2017;17:165&#x2013;178. doi: 10.1038/nri.2016.150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.150</ArticleId><ArticleId IdType="pmc">PMC5452982</ArticleId><ArticleId IdType="pubmed">28163303</ArticleId></ArticleIdList></Reference><Reference><Citation>Oishi Y., Manabe I. Macrophages in Inflammation, Repair and Regeneration. Int. Immunol. 2018;30:511&#x2013;528. doi: 10.1093/intimm/dxy054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxy054</ArticleId><ArticleId IdType="pubmed">30165385</ArticleId></ArticleIdList></Reference><Reference><Citation>Dort J., Fabre P., Molina T., Dumont N.A. Macrophages Are Key Regulators of Stem Cells during Skeletal Muscle Regeneration and Diseases. Stem Cells Int. 2019;2019:4761427. doi: 10.1155/2019/4761427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/4761427</ArticleId><ArticleId IdType="pmc">PMC6664695</ArticleId><ArticleId IdType="pubmed">31396285</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosser D.M., Zhang X. Interleukin-10: New Perspectives on an Old Cytokine. Immunol. Rev. 2008;226:205&#x2013;218. doi: 10.1111/j.1600-065X.2008.00706.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2008.00706.x</ArticleId><ArticleId IdType="pmc">PMC2724982</ArticleId><ArticleId IdType="pubmed">19161426</ArticleId></ArticleIdList></Reference><Reference><Citation>Villalta S.A., Rinaldi C., Deng B., Liu G., Fedor B., Tidball J.G. Interleukin-10 Reduces the Pathology of Mdx Muscular Dystrophy by Deactivating M1 Macrophages and Modulating Macrophage Phenotype. Hum. Mol. Genet. 2011;20:790&#x2013;805. doi: 10.1093/hmg/ddq523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq523</ArticleId><ArticleId IdType="pmc">PMC3024048</ArticleId><ArticleId IdType="pubmed">21118895</ArticleId></ArticleIdList></Reference><Reference><Citation>Marino M., Papa S., Crippa V., Nardo G., Peviani M., Cheroni C., Trolese M.C., Lauranzano E., Bonetto V., Poletti A., et al. Differences in Protein Quality Control Correlate with Phenotype Variability in 2 Mouse Models of Familial Amyotrophic Lateral Sclerosis. Neurobiol. Aging. 2015;36:492&#x2013;504. doi: 10.1016/j.neurobiolaging.2014.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.06.026</ArticleId><ArticleId IdType="pubmed">25085783</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo G., Iennaco R., Fusi N., Heath P.R., Marino M., Trolese M.C., Ferraiuolo L., Lawrence N., Shaw P.J., Bendotti C. Transcriptomic Indices of Fast and Slow Disease Progression in Two Mouse Models of Amyotrophic Lateral Sclerosis. Brain. 2013;136:3305&#x2013;3332. doi: 10.1093/brain/awt250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt250</ArticleId><ArticleId IdType="pubmed">24065725</ArticleId></ArticleIdList></Reference><Reference><Citation>Madaro L., Torcinaro A., de Bardi M., Contino F.F., Pelizzola M., Diaferia G.R., Imeneo G., Bouch&#xe8; M., Puri P.L., de Santa F. Macrophages Fine Tune Satellite Cell Fate in Dystrophic Skeletal Muscle of Mdx Mice. PLoS Genet. 2019;15:e1008408. doi: 10.1371/journal.pgen.1008408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1008408</ArticleId><ArticleId IdType="pmc">PMC6821135</ArticleId><ArticleId IdType="pubmed">31626629</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbrizio P., D&#x2019;Agostino J., Margotta C., Mella G., Panini N., Pasetto L., Sammali E., Raggi F., Sorar&#xf9; G., Bonetto V., et al. Contingent Intramuscular Boosting of P2XR7 Axis Improves Motor Function in Transgenic ALS Mice. Cell. Mol. Life Sci. 2022;79:7. doi: 10.1007/s00018-021-04070-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-021-04070-8</ArticleId><ArticleId IdType="pmc">PMC8695421</ArticleId><ArticleId IdType="pubmed">34936028</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin R.M., Warunek J., Wohlfert E.A. Therapeutic Administration of IL-10 and Amphiregulin Alleviates Chronic Skeletal Muscle Inflammation and Damage Induced by Infection. Immunohorizons. 2018;2:142&#x2013;154. doi: 10.4049/immunohorizons.1800024.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/immunohorizons.1800024</ArticleId><ArticleId IdType="pmc">PMC6223302</ArticleId><ArticleId IdType="pubmed">30417170</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng B., Wehling-Henricks M., Villalta S.A., Wang Y., Tidball J.G. IL-10 Triggers Changes in Macrophage Phenotype That Promote Muscle Growth and Regeneration. J. Immunol. 2012;189:3669&#x2013;3680. doi: 10.4049/jimmunol.1103180.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1103180</ArticleId><ArticleId IdType="pmc">PMC3448810</ArticleId><ArticleId IdType="pubmed">22933625</ArticleId></ArticleIdList></Reference><Reference><Citation>Chazaud B., Sonnet C., Lafuste P., Bassez G., Rimaniol A.C., Poron F., Authier F.J., Dreyfus P.A., Gherardi R.K. Satellite Cells Attract Monocytes and Use Macrophages as a Support to Escape Apoptosis and Enhance Muscle Growth. J. Cell Biol. 2003;163:1133&#x2013;1143. doi: 10.1083/jcb.200212046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200212046</ArticleId><ArticleId IdType="pmc">PMC2173611</ArticleId><ArticleId IdType="pubmed">14662751</ArticleId></ArticleIdList></Reference><Reference><Citation>Friese A., Kaltschmidt J.A., Ladle D.R., Sigrist M., Jessell T.M., Arber S. Gamma and Alpha Motor Neurons Distinguished by Expression of Transcription Factor Err3. Proc. Natl. Acad. Sci. USA. 2009;106:13588&#x2013;13593. doi: 10.1073/pnas.0906809106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0906809106</ArticleId><ArticleId IdType="pmc">PMC2716387</ArticleId><ArticleId IdType="pubmed">19651609</ArticleId></ArticleIdList></Reference><Reference><Citation>White P., Liebhaber S.A., Cooke N.E. 129X1/SvJ Mouse Strain Has a Novel Defect in Inflammatory Cell Recruitment. J. Immunol. 2002;168:869&#x2013;874. doi: 10.4049/jimmunol.168.2.869.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.168.2.869</ArticleId><ArticleId IdType="pubmed">11777984</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsitkanou S., della Gatta P.A., Russell A.P. Skeletal Muscle Satellite Cells, Mitochondria, and MicroRNAs: Their Involvement in the Pathogenesis of ALS. Front. Physiol. 2016;7:403. doi: 10.3389/fphys.2016.00403.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2016.00403</ArticleId><ArticleId IdType="pmc">PMC5020084</ArticleId><ArticleId IdType="pubmed">27679581</ArticleId></ArticleIdList></Reference><Reference><Citation>Chazaud B. Inflammation and Skeletal Muscle Regeneration: Leave It to the Macrophages! Trends Immunol. 2020;41:481&#x2013;492. doi: 10.1016/j.it.2020.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2020.04.006</ArticleId><ArticleId IdType="pubmed">32362490</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly R.P., Sheikh F., Kotenko S.V., Dickensheets H. The Expanded Family of Class II Cytokines That Share the IL-10 Receptor-2 (IL-10R2) Chain. J. Leukoc. Biol. 2004;76:314&#x2013;321. doi: 10.1189/jlb.0204117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0204117</ArticleId><ArticleId IdType="pubmed">15123776</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasse A., Germann M., Pechkovsky D.V., Markert A., Verres T., Stahl M., Melchers I., Luttmann W., M&#xfc;ller-Quernheim J., Zissel G. IL-10-Producing Monocytes Differentiate to Alternatively Activated Macrophages and Are Increased in Atopic Patients. J. Allergy Clin. Immunol. 2007;119:464&#x2013;471. doi: 10.1016/j.jaci.2006.09.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2006.09.030</ArticleId><ArticleId IdType="pubmed">17291860</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa T., Matsui N., Fujita K., Nodera H., Shimizu F., Miyamoto K., Takahashi Y., Kanda T., Kusunoki S., Izumi Y., et al. CSF Cytokine Profile Distinguishes Multifocal Motor Neuropathy from Progressive Muscular Atrophy. Neurol. Neuroimmunol. Neuroinflammation. 2015;2:e138. doi: 10.1212/NXI.0000000000000138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000138</ArticleId><ArticleId IdType="pmc">PMC4529282</ArticleId><ArticleId IdType="pubmed">26280014</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers J.I., Fromholt S., Sinyavskaya O., Siemienski Z., Rosario A.M., Li A., Crosby K.W., Cruz P.E., Dinunno N.M., Janus C., et al. Widespread and Efficient Transduction of Spinal Cord and Brain Following Neonatal AAV Injection and Potential Disease Modifying Effect in ALS Mice. Mol. Ther. 2015;23:53&#x2013;62. doi: 10.1038/mt.2014.180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2014.180</ArticleId><ArticleId IdType="pmc">PMC4426802</ArticleId><ArticleId IdType="pubmed">25228069</ArticleId></ArticleIdList></Reference><Reference><Citation>Strickland M.R., Ibanez K.R., Yaroshenko M., Diaz C.C., Borchelt D.R., Chakrabarty P. IL-10 Based Immunomodulation Initiated at Birth Extends Lifespan in a Familial Mouse Model of Amyotrophic Lateral Sclerosis. Sci. Rep. 2020;10:20862. doi: 10.1038/s41598-020-77564-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-77564-3</ArticleId><ArticleId IdType="pmc">PMC7705692</ArticleId><ArticleId IdType="pubmed">33257786</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W., Hu P. Skeletal Muscle Regeneration Is Modulated by Inflammation. J. Orthop. Translat. 2018;13:25&#x2013;32. doi: 10.1016/j.jot.2018.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jot.2018.01.002</ArticleId><ArticleId IdType="pmc">PMC5892385</ArticleId><ArticleId IdType="pubmed">29662788</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato Y., Ohshima T., Kondo T. Regulatory Role of Endogenous Interleukin-10 in Cutaneous Inflammatory Response of Murine Wound Healing. Biochem. Biophys. Res. Commun. 1999;265:194&#x2013;199. doi: 10.1006/bbrc.1999.1455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.1999.1455</ArticleId><ArticleId IdType="pubmed">10548513</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins S.J., Ruckerl D., Cook P.C., Jones L.H., Finkelman F.D., van Rooijen N., MacDonald A.S., Allen J.E. Local Macrophage Proliferation, Rather than Recruitment from the Blood, Is a Signature of TH2 Inflammation. Science. 2011;332:1284&#x2013;1288. doi: 10.1126/science.1204351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1204351</ArticleId><ArticleId IdType="pmc">PMC3128495</ArticleId><ArticleId IdType="pubmed">21566158</ArticleId></ArticleIdList></Reference><Reference><Citation>Welc S.S., Wehling-Henricks M., Antoun J., Ha T.T., Tous I., Tidball J.G. Differential Effects of Myeloid Cell PPAR&#x3b4; and IL-10 in Regulating Macrophage Recruitment, Phenotype, and Regeneration Following Acute Muscle Injury. J. Immunol. 2020;205:1664&#x2013;1677. doi: 10.4049/jimmunol.2000247.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2000247</ArticleId><ArticleId IdType="pmc">PMC7484367</ArticleId><ArticleId IdType="pubmed">32817369</ArticleId></ArticleIdList></Reference><Reference><Citation>Pikatza-Menoio O., Elicegui A., Bengoetxea X., Naldaiz-Gastesi N., L&#xf3;pez de Munain A., Gerenu G., Gil-Bea F.J., Alonso-Mart&#xed;n S. The Skeletal Muscle Emerges as a New Disease Target in Amyotrophic Lateral Sclerosis. J. Pers. Med. 2021;11:671. doi: 10.3390/jpm11070671.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm11070671</ArticleId><ArticleId IdType="pmc">PMC8307751</ArticleId><ArticleId IdType="pubmed">34357138</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodgers J.T., King K.Y., Brett J.O., Cromie M.J., Charville G.W., Maguire K.K., Brunson C., Mastey N., Liu L., Tsai C.-R., et al. MTORC1 Controls the Adaptive Transition of Quiescent Stem Cells from G0 to GAlert. Nature. 2014;510:393&#x2013;396. doi: 10.1038/nature13255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13255</ArticleId><ArticleId IdType="pmc">PMC4065227</ArticleId><ArticleId IdType="pubmed">24870234</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodgers J.T., Schroeder M.D., Ma C., Rando T.A. HGFA Is an Injury-Regulated Systemic Factor That Induces the Transition of Stem Cells into G Alert. Cell. Rep. 2017;19:479&#x2013;486. doi: 10.1016/j.celrep.2017.03.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.03.066</ArticleId><ArticleId IdType="pmc">PMC5468096</ArticleId><ArticleId IdType="pubmed">28423312</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatsumi R., Sankoda Y., Anderson J.E., Sato Y., Mizunoya W., Shimizu N., Suzuki T., Yamada M., Rhoads R.P., Ikeuchi Y., et al. Possible Implication of Satellite Cells in Regenerative Motoneuritogenesis: HGF Upregulates Neural Chemorepellent Sema3A during Myogenic Differentiation. Am. J. Physiol. Cell Physiol. 2009;297:C238&#x2013;C252. doi: 10.1152/ajpcell.00161.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00161.2009</ArticleId><ArticleId IdType="pubmed">19515904</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe P.A., Henderson R.D. The Role of Immune and Inflammatory Mechanisms in ALS. Curr. Mol. Med. 2011;11:246&#x2013;254. doi: 10.2174/156652411795243450.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156652411795243450</ArticleId><ArticleId IdType="pmc">PMC3182412</ArticleId><ArticleId IdType="pubmed">21375489</ArticleId></ArticleIdList></Reference><Reference><Citation>Wosiski-Kuhn M., Lyon M.S., Caress J., Milligan C. Inflammation, Immunity, and Amyotrophic Lateral Sclerosis: II. Immune-Modulating Therapies. Muscle Nerve. 2019;59:23&#x2013;33. doi: 10.1002/mus.26288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26288</ArticleId><ArticleId IdType="pubmed">29979478</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>